Covid-19 Update

Marion Fellows Excerpts
Thursday 26th November 2020

(4 years ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Matt Hancock Portrait Matt Hancock
- Hansard - - - Excerpts

Yes, absolutely—I can give both those assurances. Across Sussex, case rates are at 120. They do need to come down. Like my hon. Friend, I would like to see Sussex get to tier 1 as soon as possible, and we will keep talking to the local area. As I said earlier, all directors of public health have been invited to discussions and consultations with the public health team. That feedback fed into these decisions, but we have to make sure that those conversations continue. The key message to everybody across Sussex and in the Weald, in particular, is that if we all stick together and follow the rules, we know that we can get this virus under control, and that will then lead directly to the lifting of restrictions, which we will regularly review.

Marion Fellows Portrait Marion Fellows (Motherwell and Wishaw) (SNP) [V]
- Hansard - -

The Secretary of State will be aware of reports on the Oxford vaccine that the sub-group that suggested 90% effectiveness was due to a manufacturing error, rather than being a planned protocol. It included fewer than 3,000 people and did not have any participants over 55. Does he agree, therefore, that further research is required to verify the efficacy of the lower dose in all age groups before it can be adopted as a standard regimen?

Matt Hancock Portrait Matt Hancock
- Hansard - - - Excerpts

Questions over the interpretation of the data in the clinical trials are rightly for the Medicines and Healthcare Products Regulatory Agency, which will assess these clinical trials and will only approve a vaccine for use if it is effective and safe.